Stephanie Freel
Overview
Explore the profile of Stephanie Freel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
235
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Althuis L, Taylor S, Freeman D, Freel S, Sutton L, Bethea K, et al.
J Clin Transl Sci
. 2025 Feb;
9(1):e12.
PMID: 39911935
While clinical research intends to improve health outcomes for all, access to research participation is often limited and inequitable. Geographic proximity is a recognized barrier, thus, systemic infrastructure solutions through...
2.
Knapke J, Jenkerson M, Tsao P, Freel S, Fritter J, Helm S, et al.
J Clin Transl Sci
. 2022 Aug;
6(1):e81.
PMID: 35949655
Background: Defining key barriers to the development of a well-trained clinical research professional (CRP) workforce is an essential first step in identifying solutions for successful CRP onboarding, training, and competency...
3.
Jiang C, Parrish N, Wilen C, Li H, Chen Y, Pavlicek J, et al.
J Virol
. 2011 Aug;
85(20):10669-81.
PMID: 21835785
The great majority of human immunodeficiency virus type 1 (HIV-1) strains enter CD4+ target cells by interacting with one of two coreceptors, CCR5 or CXCR4. Here we describe a transmitted/founder...
4.
Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, et al.
J Virol
. 2011 May;
85(14):7029-36.
PMID: 21543485
Among nonneutralizing HIV-1 envelope antibodies (Abs), those capable of mediating antibody-dependent cellular cytotoxicity (ADCC) activity have been postulated to be important for control of HIV-1 infection. ADCC-mediating Ab must recognize...
5.
Lu R, Tucker J, Pickens J, Ma Y, Zinevitch T, Kirichenko O, et al.
J Med Chem
. 2009 Jun;
52(14):4481-7.
PMID: 19534463
Previously disclosed HIV (human immunodeficiency virus) attachment inhibitors, exemplified by BMS 806 (formally BMS378806, 1), are characterized by a substituted indole or azaindole ring linked to a benzoylpiperazine via a...
6.
Lu R, Tucker J, Zinevitch T, Kirichenko O, Konoplev V, Kuznetsova S, et al.
J Med Chem
. 2007 Dec;
50(26):6535-44.
PMID: 18052117
The crystal structures of many tertiary alpha-ketoamides reveal an orthogonal arrangement of the two carbonyl groups. Based on the hypothesis that the alpha-ketoamide HIV attachment inhibitor BMS 806 (formally BMS378806,...